1,037
Views
6
CrossRef citations to date
0
Altmetric
Review Articles

Benefits, toxicity and current market of cannabidiol in edibles

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Abernethy, A., and L. Schiller. 2019. FDA is committed to sound, science-based policy on CBD. Accessed August 17, 2020. https://www.fda.gov/news-events/fda-voices/fda-committed-sound-science-based-policy-cbd.
  • Ahmed, S. A., S. A. Ross, D. Slade, M. M. Radwan, I. A. Khan, and M. A. ElSohly. 2015. Minor oxygenated cannabinoids from high potency Cannabis sativa L. Phytochemistry 117:194–9. doi: 10.1016/j.phytochem.2015.04.007.
  • Aizpurua-Olaizola, O., J. Omar, P. Navarro, M. Olivares, N. Etxebarria, and A. Usobiaga. 2014. Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry 406 (29):7549–60. doi: 10.1007/s00216-014-8177-x.
  • Aizpurua-Olaizola, O., U. Soydaner, E. Öztürk, D. Schibano, Y. Simsir, P. Navarro, N. Etxebarria, and A. Usobiaga. 2016. Evolution of the cannabinoid and terpene content during the growth of cannabis sativa plants from different chemotypes. Journal of Natural Products 79 (2):324–31. doi: 10.1021/acs.jnatprod.5b00949.
  • Alphagreen Group Limited. 2021. CBD kombucha mix. Accessed November 18, 2021. https://alphagreen.io/es/woodies-cbd-mezcla-de-kombucha.html
  • Amsterdam Genetics (Masque B.V.). 2021. Accessed May 4, 2021. https://www.amsterdamgenetics.com/
  • Andonova, L., E. Ivanov, I. Pencheva, and S. Konstantinov. 2021. Elaboration and validation of HPLC/DAD method for quality control of products containing cannabidiol. Current Pharmaceutical Analysis 17 (9):1218–23. doi: 10.2174/1573412916999200805163154.
  • Azmir, J., I. S. M. Zaidul, M. M. Rahman, K. M. Sharif, A. Mohamed, F. Sahena, M. H. A. Jahurul, K. Ghafoor, N. A. N. Norulaini, and A. K. M. Omar. 2013. Techniques for extraction of bioactive compounds from plant materials: A review. Journal of Food Engineering 117 (4):426–36. doi: 10.1016/j.jfoodeng.2013.01.014.
  • Backyard Bec, C. 2021. Accessed November 18, 2021. https://www.backyardsodas.com/
  • Barrus, D. G., K. L. Capogrossi, S. C. Cates, C. K. Gourdet, N. C. Peiper, S. P. Novak, T. W. Lefever, and J. L. Wiley. 2016. Tasty THC: Promises and challenges of cannabis edibles. North Carolina: RTI Press.
  • Bar-Sela, G., D. Zalman, V. Semenysty, and E. Ballan. 2019. The effects of dosage-controlled cannabis capsules on cancer-related cachexia and anorexia syndrome in advanced cancer patients: Pilot study. Integrative Cancer Therapies 18:1534735419881498–18. doi: 10.1177/1534735419881498.
  • Bayer, R. E. 2001. Therapeutic Cannabis (Marijuana) as an antiemetic and appetite stimulant in persons with acquired immunodeficiency syndrome (AIDS). Journal of Cannabis Therapeutics 1 (3–4):5–16. doi: 10.1300/J175v01n03_02.
  • Bergamaschi, M. M., R. H. C. Queiroz, A. W. Zuardi, and J. A. S. Crippa. 2011b. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Current Drug Safety 6 (4):237–49.
  • Bergamaschi, M. M., R. H. C. Queiroz, M. H. N. Chagas, D. C. G d Oliveira, B. S D. Martinis, F. Kapczinski, J. Quevedo, R. Roesler, N. Schröder, A. E. Nardi, et al. 2011a. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 36 (6):1219–26. doi: 10.1038/npp.2011.6.
  • Berman, J. S., C. Symonds, and R. Birch. 2004. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: Results of a randomised controlled trial. Pain 112 (3):299–306. doi: 10.1016/j.pain.2004.09.013.
  • Bitencourt, R. M., and R. N. Takahashi. 2018. Cannabidiol as a therapeutic alternative for post-traumatic stress disorder: From bench research to confirmation in human trials. Frontiers in Neuroscience 12:502. doi: 10.3389/fnins.2018.00502.
  • Bjorncrantz, W. 2015. Winterized crude cannabis extracts and methods of preparation and use. WO 2015/057996 Al.
  • Blaskovich, M. A. T., A. M. Kavanagh, A. G. Elliott, B. Zhang, S. Ramu, M. Amado, G. J. Lowe, A. O. Hinton, D. M. T. Pham, J. Zuegg, et al. 2021. The antimicrobial potential of cannabidiol. Communications Biology 4 (1):7. doi: 10.1038/s42003-020-01530-y.
  • Boehnke, K. F., J. J. Gagnier, L. Matallana, and D. A. Williams. 2021. Cannabidiol use for fibromyalgia: Prevalence of use and perceptions of effectiveness in a large online survey. The Journal of Pain 22 (5):556–66. doi: 10.1016/j.jpain.2020.12.001.
  • Borgelt, L. M., K. L. Franson, A. M. Nussbaum, and G. S. Wang. 2013. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 33 (2):195–209. doi: 10.1002/phar.1187.
  • Braithwaite, I., C. Bhagavan, M. Doppen, S. Kung, K. Oldfield, and G. Newton-Howes. 2021. Medicinal applications of cannabis/cannabinoids. Current Opinion in Psychology 38:1–10. doi: 10.1016/j.copsyc.2020.06.002.
  • Brighenti, V., F. Pellati, M. Steinbach, D. Maran, and S. Benvenuti. 2017. Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp). Journal of Pharmaceutical and Biomedical Analysis 143:228–36. doi: 10.1016/j.jpba.2017.05.049.
  • Brighenti, V., M. Protti, L. Anceschi, C. Zanardi, L. Mercolini, and F. Pellati. 2021. Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds. Journal of Pharmaceutical and Biomedical Analysis 192 (113633):113633.
  • Candid Magazine. 2019. The ultimate CBD edibles, gummies & snacks guide in the UK. Accessed August 17, 2020. https://www.candidmagazine.com/cbd-edibles/?cv=1.
  • Capano, A., R. Weaver, and E. Burkman. 2020. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: A prospective cohort study. Postgraduate Medicine 132 (1):56–61. doi: 10.1080/00325481.2019.1685298.
  • Carvalho, R. K., M. L. Santos, M. R. Souza, T. L. Rocha, F. S. Guimarães, J. A. Anselmo-Franci, and R. Mazaro-Costa. 2018. Chronic exposure to cannabidiol induces reproductive toxicity in male Swiss mice. Journal of Applied Toxicology : JAT 38 (9):1215–23. doi: 10.1002/jat.3631.
  • Casarejos, M. J., J. Perucho, A. Gomez, M. P. Muñoz, M. Fernandez-Estevez, O. Sagredo, J. Fernandez Ruiz, M. Guzman, J. G D. Yebenes, and M. A. Mena. 2013. Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. Journal of Alzheimer’s Disease : JAD 35 (3):525–39. doi: 10.3233/JAD-130050.
  • Center for Drug Evaluation and Research. 2018. Non-clinical review(s). NDA 210365.
  • Ceria Inc. 2021. Accessed December 31, 2021. https://ceriainfused.com/
  • Cerino, P., C. Buonerba, G. Cannazza, J. D’Auria, E. Ottoni, A. Fulgione, A. Di Stasio, B. Pierri, and A. Gallo. 2021. A review of hemp as food and nutritional supplement. Cannabis and Cannabinoid Research 6 (1):19. doi: 10.1089/can.2020.0001.
  • Chang, C.-W., C.-W. Tung, C.-C. Tsai, Y.-T. Wu, and M.-C. Hsu. 2017. Determination of cannabinoids in hemp nut products in Taiwan by HPLC-MS/MS coupled with chemometric analysis: Quality evaluation and a pilot human study. Drug Testing and Analysis 9 (6):888–897. doi: 10.1002/dta.2062.
  • Chaturvedi, A. K. 2018. Extraction of neutraceuticals from plants by microwave assisted extraction. Systematic Reviews in Pharmacy 9 (1):31–35. doi: 10.5530/srp.2018.1.6.
  • Chen, K.-A., M. Farrar, M. Cardamone, D. Gill, R. Smith, C. T. Cowell, L. Truong, and J. A. Lawson. 2018. Cannabidiol for treating drug-resistant epilepsy in children: The New South Wales experience. The Medical Journal of Australia 209 (5):217–221. doi: 10.5694/mja18.00023.
  • Christinat, N., M.-C. Savoy, and P. Mottier. 2020. Development, validation and application of a LC-MS/MS method for quantification of 15 cannabinoids in food. Food Chemistry 318:126469.
  • Citti, C., F. Russo, S. Sgrò, A. Gallo, A. Zanotto, F. Forni, M. A. Vandelli, A. Laganà, C. M. Montone, G. Gigli, et al. 2020. Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence. Analytical and Bioanalytical Chemistry 412 (17):4009–4022., doi: 10.1007/s00216-020-02554-3.
  • Cocetta, V., P. Governa, V. Borgonetti, M. Tinazzi, G. Peron, D. Catanzaro, M. Berretta, M. Biagi, F. Manetti, S. Dall’Acqua, et al. 2021. Cannabidiol isolated from Cannabis sativa L. protects intestinal barrier from in vitro inflammation and oxidative stress. Frontiers in Pharmacology 12:641210. doi: 10.3389/fphar.2021.641210.
  • Colorado’s Best Drinks LLC. 2018. Accessed November 17, 2021. https://sparklingcbd.com/
  • Cone, E. J., R. E. Johnson, B. D. Paul, L. D. Mell, and J. Mitchell. 1988. Marijuana-laced brownies: Behavioral effects, physiologic effects, and urinalysis in humans following ingestion. Journal of Analytical Toxicology 12 (4):169–175.
  • Corroon, J., and J. A. Phillips. 2018. A cross-sectional study of cannabidiol users. Cannabis and Cannabinoid Research 3 (1):152–161. doi: 10.1089/can.2018.0006.
  • Da Silva, R. P. Rocha-Santos, and A. C. Duarte. 2016. Supercritical fluid extraction of bioactive compounds. TrAC Trends in Analytical Chemistry 76:40–51. doi: 10.1016/j.trac.2015.11.013.
  • Devinsky, O., A. D. Patel, E. A. Thiele, M. H. Wong, R. Appleton, C. L. Harden, S. Greenwood, G. Morrison, and K. Sommerville. 2018b. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. Neurology 90 (14):e1204–e1211. doi: 10.1212/WNL.0000000000005254.
  • Devinsky, O., A. D. Patel, J. H. Cross, V. Villanueva, E. C. Wirrell, M. Privitera, S. M. Greenwood, C. Roberts, D. Checketts, K. E. VanLandingham, et al. 2018a. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. The New England Journal of Medicine 378 (20):1888–1897. doi: 10.1056/NEJMoa1714631.
  • Devinsky, O., E. Marsh, D. Friedman, E. Thiele, L. Laux, J. Sullivan, I. Miller, R. Flamini, A. Wilfong, F. Filloux, et al. 2016. Cannabidiol in patients with treatment-resistant epilepsy: An open-label interventional trial. The Lancet. Neurology 15 (3):270–278. doi: 10.1016/S1474-4422(15)00379-8.
  • Diamond CBD. 2021. Chill plus delta-8 lollipop blueberry - 25mg. Accessed November 18, 2021. https://www.diamondcbd.com/products/chill-plus-delta-8-lollipop-blueberry-25mg
  • D’Onofrio, G., M. Kuchenbuch, C. Hachon-Le Camus, B. Desnous, V. Staath, S. Napuri, D. Ville, J.-M. Pedespan, A. Lépine, C. Cances, et al. 2020. Slow titration of cannabidiol add-on in drug-resistant epilepsies can improve safety with maintained efficacy in an open-label study. Frontiers in Neurology 11:829. doi: 10.3389/fneur.2020.00829.
  • DRAM Apothecary//Heyseed LLC. 2021. Accessed November 16, 2021. https://www.dramapothecary.com/
  • Durst, R., H. Danenberg, R. Gallily, R. Mechoulam, K. Meir, E. Grad, R. Beeri, T. Pugatsch, E. Tarsish, and C. Lotan. 2007. Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology 293 (6):H3602–7. doi: 10.1152/ajpheart.00098.2007.
  • ElBatsh, M. M., N. Assareh, C. A. Marsden, and D. A. Kendall. 2012. Anxiogenic-like effects of chronic cannabidiol administration in rats. Psychopharmacology 221 (2):239–247. doi: 10.1007/s00213-011-2566-z.
  • European Industrial Hemp Association. 2019. Status of Hemp Extracts in Europe. Accessed November 5, 2021. http://eiha.org/media/2019/05/EIHA-PRESS-NOTES-EXTRACTS.pdf
  • Expert Committee on Drug Dependence. World Health Organization. 2018. Cannabidiol (CBD). Critical review report Geneva.
  • Farha, M. A., O. M. El-Halfawy, R. T. Gale, C. R. MacNair, L. A. Carfrae, X. Zhang, N. G. Jentsch, J. Magolan, and E. D. Brown. 2020. Uncovering the hidden antibiotic potential of cannabis. ACS Infectious Diseases 6 (3):338–346. doi: 10.1021/acsinfecdis.9b00419.
  • Fathordoobady, F., A. Singh, D. Kitts, and A. Pratap-Singh. 2019. Hemp (Cannabis Sativa L.) extract: Anti-microbial properties, methods of extraction, and potential oral delivery. Food Reviews International 35 (7):664–684. doi: 10.1080/87559129.2019.1600539.
  • Freitas de Oliveira, C., D. Giordani, R. Lutckemier, P. D. Gurak, F. Cladera-Olivera, and L. D. Ferreira Marczak. 2016. Extraction of pectin from passion fruit peel assisted by ultrasound. LWT - Food Science and Technology 71:110–115. doi: 10.1016/j.lwt.2016.03.027.
  • Friedman, L. K., H. Peng, and R. J. Zeman. 2021. Cannabidiol reduces lesion volume and restores vestibulomotor and cognitive function following moderately severe traumatic brain injury. Experimental Neurology 346:113844. doi: 10.1016/j.expneurol.2021.113844.
  • Friese, B., M. D. Slater, R. Annechino, and R. S. Battle. 2016. Teen use of marijuana edibles: A focus group study of an emerging issue. The Journal of Primary Prevention 37 (3):303–309. doi: 10.1007/s10935-016-0432-9.
  • Garberg, H. T., R. Solberg, J. Barlinn, J. Martinez-Orgado, E.-M. Løberg, and O. D. Saugstad. 2017. High-dose cannabidiol induced hypotension after global hypoxia-ischemia in piglets. Neonatology 112 (2):143–149. doi: 10.1159/000471786.
  • Garza-Cervantes, J. A., M. Ramos-González, O. Lozano, C. Jerjes-Sánchez, and G. García-Rivas. 2020. Therapeutic applications of cannabinoids in cardiomyopathy and heart failure. Oxidative Medicine and Cellular Longevity 2020:4587024. doi: 10.1155/2020/4587024.
  • Gaston, T. E., S. B. Ampah, E. Martina Bebin, L. P. Grayson, G. R. Cutter, K. Hernando, and J. P. Szaflarski. 2021. Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy. Epilepsy & Behavior 117:107862. doi: 10.1016/j.yebeh.2021.107862.
  • Gibbs, B., A. Yates, and J. Liebling. 2019. Centre for medicinal cannabis. CBD in the UK. Towards a responsible, innovative and high-quality cannabidiol industry.
  • Go, Y. Y., S. R. Kim, D. Y. Kim, S.-W. Chae, and J.-J. Song. 2020. Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Scientific Reports 10 (1):20622. doi: 10.1038/s41598-020-77674-y.
  • Green Times Brewing LTD. 2021. Accessed November 18, 2021. https://www.greentimesbrewing.com/
  • Greydanus, D. E., E. K. Hawver, M. M. Greydanus, and J. Merrick. 2013. Marijuana: Current concepts. Frontiers in Public Health 1:42–17. doi: 10.3389/fpubh.2013.00042.
  • Grotenhermen, F. 2003. Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics 42 (4):327–360.
  • Grotenhermen, F. 2007. The toxicology of cannabis and cannabis prohibition. Chemistry & Biodiversity 4 (8):1744–1769. doi: 10.1002/cbdv.200790151.
  • Habibi, R., and S. J. Hoffman. 2018. Legalizing cannabis violates the UN drug control treaties, but progressive countries like Canada have options. Ottawa Law Review 49:1–37.
  • Hanus, L. O. 2009. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. Medicinal Research Reviews 29 (2):213–271.
  • Hazekamp, A. 2018. The trouble with CBD oil. Medical Cannabis and Cannabinoids 1 (1):65–72. doi: 10.1159/000489287.
  • Herrero, M., A. Cifuentes, and E. Ibañez. 2006. Sub- and supercritical fluid extraction of functional ingredients from different natural sources: Plants, food-by-products, algae and microalgae - A review. Food Chemistry 98 (1):136–148. doi: 10.1016/j.foodchem.2005.05.058.
  • Hess, E. J., K. A. Moody, A. L. Geffrey, S. F. Pollack, L. A. Skirvin, P. L. Bruno, J. L. Paolini, and E. A. Thiele. 2016. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex. Epilepsia 57 (10):1617–1624. doi: 10.1111/epi.13499.
  • Hudak, M., D. Severn, and K. Nordstrom. 2015. Edible cannabis-induced psychosis: Intoxication and beyond. The American Journal of Psychiatry 172 (9):911–912. doi: 10.1176/appi.ajp.2015.15030358.
  • Huestis, M. A., R. Solimini, S. Pichini, R. Pacifici, J. Carlier, and F. P. Busardò. 2019. Cannabidiol adverse effects and toxicity. Current Neuropharmacology 17 (10):974–989. doi: 10.2174/1570159X17666190603171901.
  • Iffland, K., and F. Grotenhermen. 2017. An update on safety and side effects of cannabidiol: A review of clinical data and relevant animal studies. Cannabis and Cannabinoid Research 2 (1):139–154. doi: 10.1089/can.2016.0034.
  • Ingold, J. 2014. The Denver Post. Accessed August 18, 2020. https://www.denverpost.com/2014/10/20/proposed-colorado-marijuana-edibles-ban-shows-lingering-pot-discord/
  • Irving, P. M., T. Iqbal, C. Nwokolo, S. Subramanian, S. Bloom, N. Prasad, A. Hart, C. Murray, J. O. Lindsay, A. Taylor, et al. 2018. A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis. Inflammatory Bowel Diseases 24 (4):714–724.
  • Isenmann, E., S. Veit, L. Starke, U. Flenker, and P. Diel. 2021. Effects of cannabidiol supplementation on skeletal muscle regeneration after intensive resistance training. Nutrients 13 (9):3028. doi: 10.3390/nu13093028.
  • Izzo, A. A., F. Borrelli, R. Capasso, V. D. Marzo, and R. Mechoulam. 2009. Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences 30 (10):515–527. doi: 10.1016/j.tips.2009.07.006.
  • Jiang, G., J. R. Stenzel, R. Chen, and D. Elmashni. 2013. UHPLC/MS analysis of illicit drugs. In Ultra‐high performance liquid chromatography and its applications, ed. Q. A. Xu, 253–269. New Jersey: Wiley & Sons.
  • Kearney, A. T. 2018. Research overview. https://www.kearney.com/documents/20152/4956123/The+Cannabis+Opportunity.pdf/bf18db64-c9b9-eb10-013c-4f4c250525a6?t=1578676902809.
  • King, J. W. 2019. The relationship between cannabis/hemp use in foods and processing methodology. Current Opinion in Food Science 28:32–40. doi: 10.1016/j.cofs.2019.04.007.
  • Kogan, N. M., E. Melamed, E. Wasserman, B. Raphael, A. Breuer, K. S. Stok, R. Sondergaard, A. V. V. Escudero, S. Baraghithy, M. Attar-Namdar, et al. 2015. Cannabidiol, a major non-psychotropic cannabis constituent enhances fracture healing and stimulates lysyl hydroxylase activity in osteoblasts. Journal of Bone and Mineral Research 30 (10):1905–1913. doi: 10.1002/jbmr.2513.
  • Kovacevich, N. 2019. Drink up: The next frontier in cannabis is beverages. Accessed May 3, 2021. https://www.forbes.com/sites/nickkovacevich/2019/04/15/drink-up-the-next-frontier-in-cannabis-is-beverages/?sh=6f85005e78d5
  • Kumar, K., S. Srivastav, and V. S. Sharanagat. 2021. Ultrasound assisted extraction (UAE) of bioactive compounds from fruit and vegetable processing by-products: A review. Ultrasonics Sonochemistry 70:105325. doi: 10.1016/j.ultsonch.2020.105325.
  • Lazarjani, M. P., O. Young, L. Kebede, and A. Seyfoddin. 2021. Processing and extraction methods of medicinal cannabis: A narrative review. Journal of Cannabis Research 3 (1):32. doi: 10.1186/s42238-021-00087-9.
  • Lesmes, U., and D. J. McClements. 2009. Structure–function relationships to guide rational design and fabrication of particulate food delivery systems. Trends in Food Science & Technology 20 (10):448–457. doi: 10.1016/j.tifs.2009.05.006.
  • Leweke, F. M., D. Piomelli, F. Pahlisch, D. Muhl, C. W. Gerth, C. Hoyer, J. Klosterkötter, M. Hellmich, and D. Koethe. 2012. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry 2:e94. doi: 10.1038/tp.2012.15.
  • Light, M. K., A. Orens, B. Lewandowski, and T. Pickton. 2014. Market size and demand for marijuana in colorado. Prepared for the Colorado Department of Revenue. Colorado: The Marijuana Policy Group.
  • Martínez, V., A. Iriondo De-Hond, F. Borrelli, R. Capasso, M. D D. Castillo, and R. Abalo. 2020. Cannabidiol and other non-psychoactive cannabinoids for prevention and treatment of gastrointestinal disorders: Useful nutraceuticals? International Journal of Molecular Sciences 21 (9):3067. doi: 10.3390/ijms21093067.
  • Massi, P., M. Valenti, A. Vaccani, V. Gasperi, G. Perletti, E. Marras, F. Fezza, M. Maccarrone, and D. Parolaro. 2008. 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. Journal of Neurochemistry 104 (4):1091–1100.
  • McGuire, P., P. Robson, W. J. Cubala, D. Vasile, P. D. Morrison, R. Barron, A. Taylor, and S. Wright. 2018. Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial. The American Journal of Psychiatry 175 (3):225–231. doi: 10.1176/appi.ajp.2017.17030325.
  • McPartland, J. M., and E. B. Russo. 2001. Cannabis and Cannabis Extracts. Journal of Cannabis Therapeutics 1 (3–4):103–132. doi: 10.1300/J175v01n03_08.
  • Mead, A. 2017. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law. Epilepsy & Behavior : E&B 70 (Pt B):288–291. doi: 10.1016/j.yebeh.2016.11.021.
  • Miller, I., I. E. Scheffer, B. Gunning, R. Sanchez-Carpintero, A. Gil-Nagel, M. S. Perry, R. P. Saneto, D. Checketts, E. Dunayevich, and V. Knappertz. 2020. Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: A randomized clinical trial. JAMA Neurology 77 (5):613–621. doi: 10.1001/jamaneurol.2020.0073.
  • Mishima, K., K. Hayakawa, K. Abe, T. Ikeda, N. Egashira, K. Iwasaki, and M. Fujiwara. 2005. Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke 36 (5):1071–1076. doi: 10.1161/01.STR.0000163083.59201.34.
  • Morano, A., M. Fanella, M. Albini, P. Cifelli, E. Palma, A. T. Giallonardo, and C. D. Bonaventura. 2020. Cannabinoids in the treatment of epilepsy: Current status and future prospects. Neuropsychiatric Disease and Treatment 16:381–396. doi: 10.2147/NDT.S203782.
  • Müller-Vahl, K. R. 2013. Treatment of Tourette syndrome with cannabinoids. Behavioural Neurology 27 (1):119–124. doi: 10.1155/2013/294264.
  • Müller-Vahl, K. R. 2015. Chapter 10 - Cannabinoids and the Tourette syndrome. In Cannabinoids in neurologic and mental disease, ed. L. Fattore, 227–45. San Diego, CA: Academic Press.
  • Murphy, F., P. Sales, S. Murphy, S. Averill, N. Lau, and S.-O. Sato. 2015. Baby boomers and cannabis delivery systems. Journal of Drug Issues 45 (3):293–313. doi: 10.1177/0022042615580991.
  • Nelson, K., D. Walsh, P. Deeter, and F. Sheehan. 1994. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. Journal of Palliative Care 10 (1):14–18. doi: 10.1177/082585979401000105.
  • Notcutt, W., M. Price, R. Miller, S. Newport, C. Phillips, S. Simmons, and C. Sansom. 2004. Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 “ ‘N of 1’ studies”. Anaesthesia 59 (5):440–452. doi: 10.1111/j.1365-2044.2004.03674.x.
  • Nour, A. H., A. R. Oluwaseun, A. H. Nour, M. S. Omer, and N. Ahmad. 2021. Microwave-assisted extraction of bioactive compounds (review). In Microwave heating. Electromagnetic fields causing thermal and non-thermal effects, ed. G. I. Churyumov, 1–31. London, UK: Intech Open.
  • Nuka enterprises. 2021. Accessed November 16, 2021. https://1906newhighs.com/products/
  • Oláh, A., B. I. Tóth, I. Borbíró, K. Sugawara, A. G. Szöllõsi, G. Czifra, B. Pál, L. Ambrus, J. Kloepper, E. Camera, et al. 2014. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. The Journal of Clinical Investigation 124 (9):3713–3724. doi: 10.1172/JCI64628.
  • Parker, L. A., E. M. Rock, and C. L. Limebeer. 2011. Regulation of nausea and vomiting by cannabinoids. British Journal of Pharmacology 163 (7):1411–1422. doi: 10.1111/j.1476-5381.2010.01176.x.
  • Pauli, C. S., M. Conroy, B. D. Vanden Heuvel, and S.-H. Park. 2020. Cannabidiol drugs clinical trial outcomes and adverse effects. Frontiers in Pharmacology 11:63. doi: 10.3389/fphar.2020.00063.
  • Pellegrini, M., E. Marchei, R. Pacifici, and S. Pichini. 2005. A rapid and simple procedure for the determination of cannabinoids in hemp food products by gas chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 36 (5):939–946. doi: 10.1016/j.jpba.2004.07.035.
  • Peyravian, N., S. Deo, S. Daunert, and J. J. Jimenez. 2020. Cannabidiol as a novel therapeutic for immune modulation. ImmunoTargets and Therapy 9:131–140. doi: 10.2147/ITT.S263690.
  • Present LLC. 2020. Home page. Accessed November 18, 2021. http://www.drinkpresent.com/
  • Puri, P. S. 1980. Winterization of oils and fats. Journal of the American Oil Chemists’ Society 57 (11):A848–A850. doi: 10.1007/BF02687675.
  • Radwan, M. M., M. A. ElSohly, A. T. El-Alfy, S. A. Ahmed, D. Slade, A. S. Husni, S. P. Manly, L. Wilson, S. Seale, S. J. Cutler, et al. 2015. Isolation and pharmacological evaluation of minor cannabinoids from high-potency Cannabis sativa. Journal of Natural Products 78 (6):1271–1276. doi: 10.1021/acs.jnatprod.5b00065.
  • Ripple. 2020. Accessed November 18, 2021. https://tryripple.com/
  • Robaina Cabrera, C. L., S. Keir-Rudman, N. Horniman, N. Clarkson, and C. Page. 2021. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulmonary Pharmacology & Therapeutics 69 (102047):102047.
  • Rosebud Ice Cream. 2021. Sea salt chocolate chip c(BD)ookies-box. Accessed November 18, 2021. https://rosebudicecream.com/products/cookie
  • Roselló-Soto, E., M. Koubaa, A. Moubarik, R. P. Lopes, J. A. Saraiva, N. Boussetta, N. Grimi, and F. J. Barba. 2015. Emerging opportunities for the effective valorization of wastes and by-products generated during olive oil production process: Non-conventional methods for the recovery of high-added value compounds. Trends in Food Science & Technology 45 (2):296–310. doi: 10.1016/j.tifs.2015.07.003.
  • Russo, E. B. 2007. History of cannabis and its preparations in saga, science, and sobriquet. Chemistry & Biodiversity 4 (8):1614–1648.
  • Russo, E. B. 2011. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology 163 (7):1344–1364. doi: 10.1111/j.1476-5381.2011.01238.x.
  • Saingam, W., and A. Sakunpak. 2018. Development and validation of reverse phase high performance liquid chromatography method for the determination of delta-9-tetrahydrocannabinol and cannabidiol in oromucosal spray from cannabis extract. Revista Brasileira de Farmacognosia 28 (6):669–672. doi: 10.1016/j.bjp.2018.08.001.
  • Salles, É. L., H. Khodadadi, A. Jarrahi, M. Ahluwalia, V. A. J. Paffaro, V. Costigliola, J. C. Yu, D. C. Hess, K. M. Dhandapani, and B. Baban. 2020. Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome. Journal of Cellular and Molecular Medicine 24 (21):12869–12872. doi: 10.1111/jcmm.15883.
  • Satterlund, T. D., J. P. Lee, and R. S. Moore. 2015. Stigma among California’s medical marijuana patients. Journal of Psychoactive Drugs 47 (1):10–17. doi: 10.1080/02791072.2014.991858.
  • Schiavon, A. P., J. M. Bonato, H. Milani, F. S. Guimarães, and R. M. Weffort de Oliveira. 2016. Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry 64:27–34. doi: 10.1016/j.pnpbp.2015.06.017.
  • Shannon, S., N. Lewis, H. Lee, and S. Hughes. 2019. Cannabidiol in anxiety and sleep: A large case series. The Permanente Journal 23:18–41. doi: 10.7812/TPP/18-041.
  • Sharif, K. M., M. M. Rahman, J. Azmir, A. Mohamed, M. H. A. Jahurul, F. Sahena, and I. S. M. Zaidul. 2014. Experimental design of supercritical fluid extraction – A review. Journal of Food Engineering 124:105–116. doi: 10.1016/j.jfoodeng.2013.10.003.
  • Silva, A., N. Ferreira, A. Oliveira, L. Borges, and E. Conceição. 2017. Comparison of ultrasound-assisted extraction and dynamic maceration over content of tagitinin C obtained from Tithonia diversifolia (Hemsl.) A. gray leaves using factorial design. Pharmacognosy Magazine 13 (50):270–274. doi: 10.4103/0973-1296.204555.
  • Spinella, T. C., S. H. Stewart, J. Naugler, I. Yakovenko, and S. P. Barrett. 2021. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: A randomized crossover study. Psychopharmacology 238 (7):1965–1977. doi: 10.1007/s00213-021-05823-w.
  • Stanley, C. P., W. H. Hind, C. Tufarelli, and S. E. O’Sullivan. 2015. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. Cardiovascular Research 107 (4):568–578. doi: 10.1093/cvr/cvv179.
  • Stenzel, J. R., and G. Jiang. 2008. Identification of cannabinoids in baked goods by UHPLC-MS.) Application Note: 433.
  • Sträva Craft Coffee Inc. 2021. Accessed November 18, 2021. https://www.stravacraftcoffee.com/
  • Szaflarski, J. P., E. M. Bebin, A. M. Comi, A. D. Patel, C. Joshi, D. Checketts, J. C. Beal, L. C. Laux, L. M. De Boer, M. H. Wong, et al. 2018. Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results. Epilepsia 59 (8):1540–1548. doi: 10.1111/epi.14477.
  • Taura, F., S. Sirikantaramas, Y. Shoyama, K. Yoshikai, Y. Shoyama, and S. Morimoto. 2007. Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type Cannabis sativa. FEBS Letters 581 (16):2929–2934. doi: 10.1016/j.febslet.2007.05.043.
  • The Lagunitas Brewing Company. 2021. Products. Accessed November 18, 2021. https://hifihops.com/products
  • Thiele, E. A., E. D. Marsh, J. A. French, M. Mazurkiewicz-Beldzinska, S. R. Benbadis, C. Joshi, P. D. Lyons, A. Taylor, C. Roberts, K. Sommerville, et al. 2018. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet 391 (10125):1085–1096. doi: 10.1016/S0140-6736(18)30136-3.
  • Tireki, S. 2021. A review on packed non-alcoholic beverages: Ingredients, production, trends and future opportunities for functional product development. Trends in Food Science & Technology 112:442–454. doi: 10.1016/j.tifs.2021.03.058.
  • Torres-Moreno, M. del C. 2015. Eficacia y tolerabilidad de placebo y cannabinoides en esclerosis múltiple. PhD diss., Universidad Autónoma de Barcelona.
  • Tzimas, P. S., E. A. Petrakis, M. Halabalaki, and L. A. Skaltsounis. 2021. Effective determination of the principal non-psychoactive cannabinoids in fiber-type Cannabis sativa L. by UPLC-PDA following a comprehensive design and optimization of extraction methodology. Analytica Chimica Acta 1150:338200. doi: 10.1016/j.aca.2021.338200.
  • Urits, I., K. Gress, K. Charipova, K. Habib, D. Lee, C. Lee, J. W. Jung, H. Kassem, E. Cornett, A. Paladini, et al. 2020. Use of cannabidiol (CBD) for the treatment of chronic pain. Best Practice & Research. Clinical Anaesthesiology 34 (3):463–477. doi: 10.1016/j.bpa.2020.06.004.
  • Van de Donk, T., Niesters, M. Kowal, M. A. Olofsen, E. Dahan, A. and M. van Velzen. 2019. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain 160 (4):860–869. doi: 10.1097/j.pain.0000000000001464.
  • Vandrey, R., J. C. Raber, M. E. Raber, B. Douglass, C. Miller, and M. O. Bonn-Miller. 2015. Cannabinoid dose and label accuracy in edible medical cannabis products. Jama 313 (24):2491–2493. doi: 10.1001/jama.2015.6613.
  • Vlad, R.-A., L. Farczadi, S. Imre, A. D. Ciurba, N. Todoran, E. Redai, P. Antonoaea, and D. L. Muntean. 2019. New UHPLC method for cannabidiol determination in hard capsules. Acta Medica Marisiensis 65 (2):45–48. doi: 10.2478/amma-2019-0007.
  • Volkow, N. D., R. D. Baler, W. M. Compton, and S. R. B. Weiss. 2014. Adverse health effects of marijuana use. The New England Journal of Medicine 370 (23):2219–2227. doi: 10.1056/NEJMra1402309.
  • Wang, J. V., S. Shah, C. A. Albornoz, and N. Saedi. 2021. Consumer interest in topical cannabidiol: An examination of online search trends from 2015 to 2019. Clinics in Dermatology in Dermatology 39 (6):1014–1017. doi: 10.1016/j.clindermatol.2020.11.007.
  • Winiger, E. A., L. N. Hitchcock, A. D. Bryan, and L. Cinnamon Bidwell. 2021. Cannabis use and sleep: Expectations, outcomes, and the role of age. Addictive Behaviors 112:106642. doi: 10.1016/j.addbeh.2020.106642.
  • Wong, H., and B. E. Cairns. 2019. Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain. Archives of Oral Biology 104:33–39. doi: 10.1016/j.archoralbio.2019.05.028.
  • Woolridge, E., S. Barton, J. Samuel, J. Osorio, A. Dougherty, and A. Holdcroft. 2005. Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management 29 (4):358–367. doi: 10.1016/j.jpainsymman.2004.07.011.
  • Xerilabs LLC. 2021. Accessed November 16, 2021. https://www.stberniescbd.com/.
  • Zettler, P. J., and E. Lietzan. 2020. A special exception for CBD in foods and supplements? Drug Discovery Today 25 (3):467–469. doi: 10.1016/j.drudis.2019.10.013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.